Published in Ann Thorac Surg on November 01, 1973
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol (2007) 7.33
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA (1994) 4.01
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg (1996) 2.49
Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery (1970) 2.34
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys (1990) 2.11
Congenital heart block in newborns of mothers with connective tissue disease. Circulation (1977) 2.02
Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62
Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg (1997) 1.61
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol (2000) 1.54
Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg (1999) 1.51
Early discharge after modified radical mastectomy. Am J Surg (1986) 1.47
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol (1996) 1.43
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Carcinoid tumors of the appendix. Ann Surg (1993) 1.36
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg (1991) 1.30
Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1984) 1.30
Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol (1988) 1.29
Histopathology of orthotopic canine cardiac homografts. Lab Invest (1968) 1.28
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26
Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol (1991) 1.26
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Electrocardiograms of dogs with heart homografts. Circulation (1966) 1.23
Preoperative radiation therapy for sarcoma of soft tissue. Cancer (1981) 1.12
Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer (1991) 1.11
Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg (1984) 1.11
Intraoperative irradiation for unresectable pancreatic carcinoma. Cancer (1982) 1.11
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther (2004) 1.11
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst (1995) 1.09
Postoperative radiation therapy of rectal cancer. Int J Radiat Oncol Biol Phys (1987) 1.08
Heart graft arteriosclerosis. Transplant Proc (1971) 1.08
Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev (Orlando) (1987) 1.08
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Natural history of Wolff-Parkinson-White syndrome discovered in infancy. Am J Cardiol (1978) 1.07
Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost +/- resection. Int J Radiat Oncol Biol Phys (1983) 1.04
Long-distance transportation of human hearts for transplantation. Ann Thorac Surg (1978) 1.03
Pathological studies in rectal cancer. Cancer (1980) 1.03
Nonpenetrating vascular injury to the subclavian artery. J Vasc Surg (1988) 1.02
Arteries in canine cardiac homografts. Ultrastructure during acute rejection. Lab Invest (1969) 1.01
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg (1981) 1.01
Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. Arch Surg (1986) 1.01
Host immune response to a common cell-surface antigen in human sarcomas. N Engl J Med (1971) 1.01
Endocarditis due to accidental penetrating foreign bodies. Am J Med (1976) 1.00
Participation of antibodies in acute cardiac-allograft rejection in man. N Engl J Med (1969) 0.98
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196. J Clin Oncol (2000) 0.98
Serial coronary angioplasty for atherosclerosis following heart transplantation. J Heart Transplant (1985) 0.98
Role of beta-adrenergic receptors in the circulatory response to hypoxia. Am J Physiol (1969) 0.98
The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma. J Clin Oncol (1987) 0.98
Complete repair of tetralogy associated with sickle cell anemia and G-6-PD deficiency. J Thorac Cardiovasc Surg (1976) 0.98
Benign smooth muscle tumors of the gastrointestinal tract. A 24-year experience. Ann Surg (1990) 0.97
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. J Am Acad Dermatol (1983) 0.96
Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma. J Clin Oncol (1989) 0.96
Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer. Eur J Cancer (1995) 0.96
The management of ductal and lobular breast cancer. Surg Oncol (1999) 0.95
Heart transplantation--1978. Surg Clin North Am (1978) 0.95
Responses to electrical and reflex autonomic stimulation in dogs with cardiac transplantation before and after reinnervation. J Thorac Cardiovasc Surg (1970) 0.94
Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients. Transplantation (1986) 0.94
Transplantation of the heart. Adv Surg (1966) 0.94
Successful orthotopic canine heart transplantation after 24 hours of in vitro preservation. J Thorac Cardiovasc Surg (1981) 0.93
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1999) 0.92
Observations on the natural history of pulmonary artery coarctations. Circulation (1972) 0.91
Anomalous origin of the right coronary artery from the main pulmonary artery. Am J Cardiol (1972) 0.91
Changing concepts in the treatment of penetrating cardiac injuries. J Trauma (1977) 0.91
Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer (1983) 0.90
Reversal of selenium deficiency with oral selenium. N Engl J Med (1981) 0.90
Rhabdomyoma of the heart: ultrastructural study of three cases. Lab Invest (1976) 0.90
Transplantation of canine cadaver hearts after short-term preservation. Transplantation (1967) 0.90
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081. Cancer (1988) 0.89
pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival. Breast Cancer Res Treat (1992) 0.89
Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg (1983) 0.89
Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay. J Neurosurg (1979) 0.89
Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer. Arch Surg (1986) 0.88
Multivariate analysis. Some guidelines for physicians. JAMA (1983) 0.88
Circulatory assistance with a cardiac allograft after exclusion of the canine left ventricle. Ann Thorac Surg (1982) 0.88
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer. Breast (2003) 0.87
Conservative treatment of early-stage breast cancer in a medically indigent population. J Natl Med Assoc (1995) 0.87
Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control (1992) 0.87
Beta 2 microglobulins in rejection and cytomegalovirus infection in a cardiac transplant recipient. Transplant Proc (1982) 0.87
Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst (1980) 0.87
Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma. Surgery (1978) 0.87
Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology (1993) 0.86
Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol (1992) 0.86
Cardiac transplantation without complete cardiac denervation. The role of the afferent receptors. Am Heart J (1966) 0.86
Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer (1991) 0.86
Experiences in heart transplantation. Technic, physiology and rejection. Am J Cardiol (1968) 0.85
Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol (1996) 0.85